Sizing the relevant oncology population for innovative nutritional solutions

Business Challenge

Our client needed quantitative evidence for to justify investing in R&D and identify the most relevant oncology patient populations.

Solution Delivered

An in-depth sizing of cancer patients across 10 countries, segmented by treatment type, specific treatment, and resulting gastrointestinal symptoms.